Acorah Software Products - Accounts Production19.2.450falsetruefalsetrueNo description of principal activity9 October 202431 October 202531 October 202516007020Dr Saidalavi Kaithakkodeniso4217:GBPiso4217:EURiso4217:USDxbrli:sharesxbrli:purexbrli:pure160070202024-10-08160070202025-10-31160070202024-10-092025-10-3116007020frs-core:CurrentFinancialInstruments2025-10-3116007020frs-bus:PrivateLimitedCompanyLtd2024-10-092025-10-3116007020frs-bus:FilletedAccounts2024-10-092025-10-3116007020frs-bus:Micro-entities2024-10-092025-10-3116007020frs-bus:AuditExempt-NoAccountantsReport2024-10-092025-10-3116007020frs-bus:Director12024-10-092025-10-31
Registered number: 16007020
Therasphere Limited
Unaudited Financial Statements
For the Period 9 October 2024 to 31 October 2025
Therasphere Limited
Balance Sheet
As At 31 October 2025
Balance Sheet
Registered number: 16007020
31 October 2025
£
Current assets
114,287
Creditors: Amounts Falling Due Within One Year
(31,487)
NET CURRENT ASSETS
82,800
TOTAL ASSETS LESS CURRENT LIABILITIES
82,800
Accruals and deferred income
(299)
NET ASSETS
82,501
CAPITAL AND RESERVES
82,501
Notes
1.General Information
Therasphere Limited is a private company, limited by shares, incorporated in England & Wales, registered number 16007020. The registered office is 72 Braemar Avenue, Bristol, BS7 0TQ.
2.Average Number of Employees
Average number of employees, including directors, during the period was: 1
1
For the period ending 31 October 2025 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.
The member has not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.
The director acknowledges his responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.
These accounts have been prepared in accordance with the micro-entity provisions and delivered in accordance with the provisions applicable to companies subject to the small companies regime.